Literature DB >> 29928942

Interventions to decrease short-term peripheral venous catheter-related bloodstream infections: impact on incidence and mortality.

P Saliba1, A Hornero2, G Cuervo1, I Grau1, E Jimenez1, D Berbel3, P Martos4, J M Verge4, C Tebe5, J M Martínez-Sánchez6, E Shaw1, L Gavaldà7, J Carratalà8, M Pujol1.   

Abstract

BACKGROUND: Short-term peripheral venous catheters are a significant source of healthcare-acquired bloodstream infections and a preventable cause of death. AIM: To assess the effectiveness of interventions applied to reduce the incidence and mortality associated with short-term peripheral venous catheter-related bloodstream infections (PVCR-BSIs).
METHODS: The intervention included continuous PVCR-BSI surveillance, implementation of preventive measures related to catheter insertion and maintenance in accordance with evidence-based recommendations and the hospital's own data, front-line staff educational campaigns, and assessment of adherence to hospital guidelines by ward rounds. A Poisson regression model was used to estimate the trend of rate per year.
FINDINGS: From January 2003 to December 2016, 227 episodes of PVCR-BSI were identified among hospitalized patients at a university hospital. The mean age of patients was 67 years (standard deviation 14 years), 69% were male and the median Charlson score was 3 (interquartile range 2-5). Staphylococcus aureus caused 115 (50.7%) episodes. Thirty-day mortality was 13.2%. After implementation of the intervention, the incidence of PVCR-BSIs decreased significantly from 30 episodes in 2003 (1.17 episodes/10,000 patient-days) to eight episodes in 2016 (0.36/10,000 patient-days). The number of episodes caused by S. aureus decreased from 18 episodes in 2003 (0.70/10,000 patient-days) to three episodes in 2016 (0.14/10,000 patient-day), and mortality decreased from seven cases in 2003 (0.27/10,000 patient-days) to zero cases in 2016 (0.00/10,000 patient-days).
CONCLUSIONS: Surveillance, implementation of a multi-modal strategy and periodical assessment of healthcare workers' adherence to hospital guidelines led to a sustained reduction in PVCR-BSIs. This reduction had a major impact on S. aureus BSI rates and associated mortality.
Copyright © 2018 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bloodstream infection; Catheter-related bloodstream infection; Mortality; PVCR-BSI; S. aureus bloodstream infection; Short-term peripheral venous catheter

Mesh:

Year:  2018        PMID: 29928942     DOI: 10.1016/j.jhin.2018.06.010

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  4 in total

1.  Microbiological colonization of peripheral venous catheters: a prospective observational study in a Swedish county hospital.

Authors:  D Juhlin; F Hammarskjöld; S Mernelius; K Taxbro; S Berg
Journal:  Infect Prev Pract       Date:  2021-06-07

2.  Clinical characteristics of peripheral venous catheter-associated gram-negative bloodstream infection among patients with malignancy.

Authors:  Toshiharu Sasaki; Sohei Harada; Shungo Yamamoto; Daisuke Ohkushi; Brian Hayama; Koichi Takeda; Kosuke Hoashi; Joji Shiotani; Kazumi Takehana; Yohei Doi
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

3.  Clinical Characteristics And Risk Factors In Mixed-Enterococcal Bloodstream Infections.

Authors:  Cheng Zheng; Jiachang Cai; Haizhou Liu; Shufang Zhang; Li Zhong; Nanxia Xuan; Hongwei Zhou; Kai Zhang; Yesong Wang; Xijiang Zhang; Baoping Tian; Zhaocai Zhang; Changming Wang; Wei Cui; Gensheng Zhang
Journal:  Infect Drug Resist       Date:  2019-10-31       Impact factor: 4.003

4.  Trends in the epidemiology of catheter-related bloodstream infections; towards a paradigm shift, Spain, 2007 to 2019.

Authors:  Laia Badia-Cebada; Judit Peñafiel; Patrick Saliba; Marta Andrés; Jordi Càmara; Dolors Domenech; Emili Jiménez-Martínez; Anna Marrón; Encarna Moreno; Virginia Pomar; Montserrat Vaqué; Enric Limón; Úrsula Masats; Miquel Pujol; Oriol Gasch
Journal:  Euro Surveill       Date:  2022-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.